Revive Therapeutics RVVTF Stock
Revive Therapeutics Price Chart
Revive Therapeutics RVVTF Financial and Trading Overview
| Revive Therapeutics stock price | 0.02 USD |
| Previous Close | 0.02 USD |
| Open | 0.02 USD |
| Bid | 0.02 USD x 1000000 |
| Ask | 0.02 USD x 1000000 |
| Day's Range | 0.02 - 0.02 USD |
| 52 Week Range | 0.006 - 0.06 USD |
| Volume | 271.75K USD |
| Avg. Volume | 278.33K USD |
| Market Cap | 8.71M USD |
| Beta (5Y Monthly) | -1.828 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RVVTF Valuation Measures
| Enterprise Value | 8.73M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -6.696 |
Trading Information
Revive Therapeutics Stock Price History
| Beta (5Y Monthly) | -1.828 |
| 52-Week Change | 17.64% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 0.06 USD |
| 52 Week Low | 0.006 USD |
| 50-Day Moving Average | 0.02 USD |
| 200-Day Moving Average | 0.02 USD |
RVVTF Share Statistics
| Avg. Volume (3 month) | 278.33K USD |
| Avg. Daily Volume (10-Days) | 320.64K USD |
| Shares Outstanding | 435.68M |
| Float | 429.35M |
| Short Ratio | N/A |
| % Held by Insiders | 1.51% |
| % Held by Institutions | 0.0030% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | June 30, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -16.44% |
| Return on Equity (ttm) | -1108.41% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -1303480 USD |
| Net Income Avi to Common (ttm) | -10623899 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 12.67K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 70.77K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.036 |
| Book Value Per Share (mrq) | -0.00577944 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -156711 USD |
| Levered Free Cash Flow (ttm) | 240.13K USD |
Profile of Revive Therapeutics
| Country | United States |
| State | ON |
| City | Toronto |
| Address | The Canadian Venture Building |
| ZIP | M5C 1P1 |
| Phone | 888-901-0036 |
| Website | https://revivethera.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It develops Bucillamine, a disease-modifying anti-rheumatic drug, for the treatment of infectious diseases, including influenza and COVID-19, as well as to treat pandemic influenza, emerging infectious diseases, and medical countermeasure incidents and attacks. The company also develops Psilocybin, which is in Phase 1 clinical study for treating methamphetamine use disorder; and Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases. Revive Therapeutics Ltd. is based in Toronto, Canada.
Q&A For Revive Therapeutics Stock
What is a current RVVTF stock price?
Revive Therapeutics RVVTF stock price today per share is 0.02 USD.
How to purchase Revive Therapeutics stock?
You can buy RVVTF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Revive Therapeutics?
The stock symbol or ticker of Revive Therapeutics is RVVTF.
Which industry does the Revive Therapeutics company belong to?
The Revive Therapeutics industry is Drug Manufacturers - Specialty & Generic.
How many shares does Revive Therapeutics have in circulation?
The max supply of Revive Therapeutics shares is 435.68M.
What is Revive Therapeutics Price to Earnings Ratio (PE Ratio)?
Revive Therapeutics PE Ratio is now.
What was Revive Therapeutics earnings per share over the trailing 12 months (TTM)?
Revive Therapeutics EPS is -0.02 USD over the trailing 12 months.
Which sector does the Revive Therapeutics company belong to?
The Revive Therapeutics sector is Healthcare.